Government launches scheme to deliver five “breakthrough technologies” a year

BMJ

9 November 2017 - Is the promise of faster access to transformative medicine a good deal for patients or an inducement to keep drug companies in the UK?

The government has promised NHS patients faster access to new drugs or technologies at no additional cost and without compromising safety.

The Accelerated Access Review follows almost 20 reports and reviews of innovation in the NHS over the past decade. Its aims have been generally welcomed despite doubts that all or any of them can be achieved, never mind all three at once.

Read BMJ news article

Michael Wonder

Posted by:

Michael Wonder